Fertility Drug and Surgery Market Seeking Excellent Growth By 2027
Market Highlights
The global fertility
drug and surgery market is expected to grow at an approximate CAGR of 9.8%
during the forecast period of 2018–2023.
Infertility is a condition when a couple can't get pregnant
despite having unprotected sex. Infertility may cause due to a defect in a
reproductive system such as abnormal production of sperm due to sexually
transmitted diseases or other factors.
There are various symptoms faced by infertile men and woman.
In woman the irregular menstrual periods, hormone fluctuation, and in men the
semen abnormalities, pelvic infections or sexually transmitted diseases are the
common symptoms.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/7588
The key factors responsible for driving the market growth
are an increase in global infertility rates, increasing obesity, delayed
pregnancies in women, increase in gamete donations, increase in disposable
income, also rising healthcare expenditure worldwide is promoting the market
growth.
The increasing cases of infertility due to a sedentary
lifestyle and other factors may boost the demand for fertility treatment
products and drive the market growth.
There are various treatment & diagnosis methods to cure
this problem for both male and female patient.
In 2017, Merck KGaA announced that the European Commission
granted approval for the company’s new Pergoveris pen. This product was the
first product with a Follicle Stimulating Hormone (FSH) and Luteinizing Hormone
(LH) combination in a ready–to use liquid form.
However, the factors such as cost constraints, complications
related to treatments and low awareness level among the population may boost
the market growth during the forecasted period.
Segmentation
The global fertility drug and surgery market are segmented
on the basis of underlying cause, drug, procedures, end user, and region.
On the basis of the underlying cause, the global fertility
drug and surgery market is segmented into male and female. By drug, the global
fertility drug and surgery market is categorized into clomiphene citrate,
letrozole, Serophene, hormone treatment, gonadotrophins
aromatase inhibitors, estrogen receptor modulators, dopamine
agonists, metformin hydrochloride and others. On the basis of procedures, the
global fertility drug and surgery market is segmented into hysteroscopy,
laparoscopy and robotic laparoscopy, laparotomy/open surgery, egg retrieval,
varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy),
sperm retrieval (epididymal aspiration). By end-user, the global fertility drug
and surgery market is categorized into fertility clinics, hospitals, clinical
research institutes, and others.
On the basis of region, the global fertility drug and
surgery market is segmented into the Americas, Europe, Asia-Pacific, and the
Middle East & Africa. The Americas is expected to hold the largest market
share and the Middle East & Africa with a low market share during the
forecasted period.
Regional Analysis
The Americas dominates the global market for fertility drug
and surgery owing to the growing female geriatric population, increase in
gamete donations, an increase in clinical research within the region.
Additionally, the increasing awareness about the fertility treatment and
presence of developed economies and healthcare sector within the region dives
the market growth during the forecast period. In 2017, it was estimated that
Europe stood second in the global fertility drug and surgery market due to the
increasing prevalence of sexually transmitted diseases such as gonorrhea,
chlamydia, mumps, and others which produces the abnormal sperm. Asia-Pacific
was the fastest growing region for the global fertility drug and surgery market
in 2017. Factors such as increased innovation and awareness about the available
treatment methods fuel the market growth within the region.
On the other hand, the Middle East and Africa hold the least
share in the global fertility drug and surgery market. The presence of poor
economies and low per capita income, especially within the African region make
the market to lag within the region. Most of the market share within this
region is estimated to be held by the Middle East.
Key Players
Some of the key players in the global fertility drug and
surgery market are Eli Lilly, Baxter Healthcare Corporation, Ferring
Pharmaceuticals, Inc., Merck & Co. Pharmaceutical Company, Noven
Pharmaceuticalorganon, Inc., Janssen Pharmaceuticals Inc., Personal Products
Company, Pfizer, Inc., Procter & Gamble Pharmaceuticals, Emd Serono, Inc.,
and others.
Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/fertility-drug-surgery-market-7588
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment